Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Soon after Ozempic hit the market in 2017, Novo Nordisk began to market the drug as a potential weight loss drug
In the U.S., its not FDA-approved for general use, meaning its typically available through compounding pharmacies or research supply companies
In addition, tirzepatide is also approved in the European Union for weight management in adults with obesity or with overweight and at least one weight-related comorbidity
Begin at 0.5 mg and plan for extended stays at each dose level
Increased Risks for Older Adults As we get older, our bodies often process medications and alcohol differently
US$ 29.26
US$ 27.39
US$ 27.18
US$ 22.36
US$ 20.50
